04/25/2024
6:15 AM | Sage Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
5:46 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
3:07 PM | Sage Therapeutics (Filer)
| Form DEF 14A | |
04/24/2024
3:10 PM | Sage Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024
3:13 PM | Sage Therapeutics (Filer)
| Form ARS | |
04/19/2024
7:31 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
5:35 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
03/26/2024
7:34 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
6:49 AM | Sage Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2024
6:20 AM | Sage Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
6:09 AM | RTW INVESTMENTS, LP (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
5:45 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
4:13 PM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/13/2024
5:28 AM | Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024
5:28 AM | BB BIOTECH AG (Filed by)
BB BIOTECH AG (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024
9:17 AM | Sage Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/31/2024
4:25 PM | Sage Therapeutics (Subject)
| Form SC TO-I/A | |
01/31/2024
3:50 PM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2024
9:04 AM | Sage Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
01/23/2024
7:13 AM | Sage Therapeutics (Subject)
| Form SC TO-I | |
01/08/2024
5:45 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:07 PM | IGUCHI KIMI (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | Golumbeski George (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | FRATES JAMES M (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | PAUL STEVEN M (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | Federer Jessica (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
7:30 AM | Sage Therapeutics (Filer)
| Form DEF 14A | |
12/19/2023
7:32 AM | Sage Therapeutics (Filer)
| Form DEFA14A | |
12/08/2023
8:00 AM | Sage Therapeutics (Subject)
| Form SC TO-C | |
12/08/2023
7:30 AM | Sage Therapeutics (Filer)
| Form PRE 14A | |
12/08/2023
7:30 AM | Sage Therapeutics (Filer)
| Form PRE 14A | |
11/07/2023
6:39 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
6:29 AM | Sage Therapeutics (Filer)
| Form 424B5 | |
11/07/2023
6:00 AM | Sage Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
5:46 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/31/2023
5:45 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
7:51 AM | Barrett Elizabeth (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
6:49 AM | Sage Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/07/2023
6:20 AM | Sage Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2023
5:45 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
These AI trades triggered this morning (545% return) (Ad) If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy |
07/10/2023
7:44 AM | Sage Therapeutics (Subject)
| Form SC 13G/A | |
07/10/2023
7:44 AM | Sage Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
05/11/2023
7:58 AM | Barrett Elizabeth (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:21 AM | Sage Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2023
5:45 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
